LONDON--(BUSINESS WIRE)--Researchers at the Imperial College London will study individuals with genetic mutations associated with Parkinson’s disease (PD) as one of 32 clinical sites of the Parkinson’s Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation for Parkinson’s Research. The study is seeking volunteers of Ashkenazi Jewish background to participate.
Help employers find you! Check out all the jobs and post your resume.
